Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the lapse-in-funding notice about data currency.
    Difference
    0.4%
    Check dated 2026-02-11T05:56:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center status and a site revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:52:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T03:50:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.3.3 to v3.3.4; no study content, endpoints, eligibility criteria, or navigation were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:13.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations have been consolidated into a single 'Locations' section listing multiple US sites (Arizona, Colorado, Illinois, Michigan, New Jersey, New York, South Carolina, Virginia), replacing the previous state-specific subsections; the page footer now shows Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T13:30:14.000Z thumbnail image

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.